Weill Cornell Medical College News
[an error occurred while processing this directive]Waging War on the Brain: Conference Examines Psychological and Neurological Consequences of Military Conflict
War is hell, as the old saying goes -- with loss of life and limb, destruction of infrastructure and the environment, and devastating costs. Recent biomedical research has shed light on another pernicious consequence of military conflict: psychological and neurological conditions like post-traumatic stress disorder and traumatic brain injury. At the same time, researchers have worked to uncover some of the motives and meanings of war.
War is hell, as the old saying goes -- with loss of life and limb, destruction of infrastructure and the environment, and devastating costs. Recent biomedical research has shed light on another pernicious consequence of military conflict: psychological and neurological conditions like post-traumatic stress disorder and traumatic brain injury. At the same time, researchers have worked to uncover some of the motives and meanings of war.
$2 Million National Institute on Aging Grant Funds Pain Management for NYC Seniors
The National Institute on Aging (NIA) has awarded Weill Cornell Medical College a $2 million grant over the next five years to fund an Edward R. Roybal Center for Research on Applied Gerontology, one of 12 such centers nationally. The grant will create the Cornell-Columbia Translational Research Institute on Pain in Later Life (TRIPLL), a multi-institutional and interdisciplinary collaboration focused on implementing innovative strategies for improving pain management among older adults.
One of the country's most extensive community-centered research initiatives in the field of aging, TRIPLL is expected to reach more than 300,000 New York metro-area seniors.
The National Institute on Aging (NIA) has awarded Weill Cornell Medical College a $2 million grant over the next five years to fund an Edward R. Roybal Center for Research on Applied Gerontology, one of 12 such centers nationally. The grant will create the Cornell-Columbia Translational Research Institute on Pain in Later Life (TRIPLL), a multi-institutional and interdisciplinary collaboration focused on implementing innovative strategies for improving pain management among older adults.
One of the country's most extensive community-centered research initiatives in the field of aging, TRIPLL is expected to reach more than 300,000 New York metro-area seniors.
New Diabetes Screening Tool Promotes Early Detection in Adults
Nearly a third of those with diabetes don't know they are ill. Now, researchers at Weill Cornell Medical College have developed a new screening tool aimed at improving early diagnosis in order to prevent or delay onset of the disease in adults. Details are published in the Dec. 1 Annals of Internal Medicine.
Nearly a third of those with diabetes don't know they are ill. Now, researchers at Weill Cornell Medical College have developed a new screening tool aimed at improving early diagnosis in order to prevent or delay onset of the disease in adults. Details are published in the Dec. 1 Annals of Internal Medicine.
NewYork-Presbyterian, Weill Cornell and Columbia University Establish Integrated Eating Disorders Center
NewYork-Presbyterian Hospital, Weill Cornell Medical College and Columbia University College of Physicians and Surgeons, in affiliation with the New York State Psychiatric Institute, announced the creation of an integrated eating disorders center. Opening today is a key clinical component of this new center -- The Outlook at NewYork-Presbyterian Hospital/Westchester Division in White Plains. The only specialized inpatient eating disorders program in New York state, The Outlook will provide treatment for adolescents and adults with anorexia nervosa, bulimia nervosa, as well as binge eating and other eating-related disorders.
Also under the umbrella of the integrated center are outpatient treatment programs at NewYork-Presbyterian/ Westchester, the New York State Psychiatric Institute and on East 60th St. in Manhattan.
NewYork-Presbyterian Hospital, Weill Cornell Medical College and Columbia University College of Physicians and Surgeons, in affiliation with the New York State Psychiatric Institute, announced the creation of an integrated eating disorders center. Opening today is a key clinical component of this new center -- The Outlook at NewYork-Presbyterian Hospital/Westchester Division in White Plains. The only specialized inpatient eating disorders program in New York state, The Outlook will provide treatment for adolescents and adults with anorexia nervosa, bulimia nervosa, as well as binge eating and other eating-related disorders.
Also under the umbrella of the integrated center are outpatient treatment programs at NewYork-Presbyterian/ Westchester, the New York State Psychiatric Institute and on East 60th St. in Manhattan.
Diabetes Surgery Summit Consensus Lays Foundation for New Field of Medicine
A first-of-its-kind consensus statement on diabetes surgery is published online today in the Annals of Surgery. The report illustrates the findings of the first international consensus conference -- Diabetes Surgery Summit (DSS) -- where an international group of more than 50 scientific and medical experts agreed on a set of evidence-based guidelines and definitions that are meant to guide the use and study of gastrointestinal surgery to treat type 2 diabetes. The document is considered to be the foundation of diabetes surgery as a medical discipline of its own.
The Diabetes Surgery Summit was held at the Catholic University of Rome, Italy, under the auspices of 22 international medical and scientific organizations, notably including the American Diabetes Association, the American Society for Metabolic and Bariatric Surgery, Diabetes United Kingdom, The Obesity Society and the European Association for the Study of Diabetes. A draft of the DSS consensus statement was critically reviewed by official representatives of these organizations during the recent 1st World Congress on Interventional Therapies for Type 2 Diabetes, held in New York City and organized by NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
A first-of-its-kind consensus statement on diabetes surgery is published online today in the Annals of Surgery. The report illustrates the findings of the first international consensus conference -- Diabetes Surgery Summit (DSS) -- where an international group of more than 50 scientific and medical experts agreed on a set of evidence-based guidelines and definitions that are meant to guide the use and study of gastrointestinal surgery to treat type 2 diabetes. The document is considered to be the foundation of diabetes surgery as a medical discipline of its own.
The Diabetes Surgery Summit was held at the Catholic University of Rome, Italy, under the auspices of 22 international medical and scientific organizations, notably including the American Diabetes Association, the American Society for Metabolic and Bariatric Surgery, Diabetes United Kingdom, The Obesity Society and the European Association for the Study of Diabetes. A draft of the DSS consensus statement was critically reviewed by official representatives of these organizations during the recent 1st World Congress on Interventional Therapies for Type 2 Diabetes, held in New York City and organized by NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
New Cancer Target for Non-Hodgkin's Lymphoma Featured in Nature Medicine
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells. By exploiting this mechanism, researchers have been able to powerfully suppress tumor formation in lab testing and in animal models.
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells. By exploiting this mechanism, researchers have been able to powerfully suppress tumor formation in lab testing and in animal models.
Patient Receives World's First Delivery of Intra-arterial Avastin Directly Into a Malignant Brain Tumor
Neurosurgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical Center performed the world's first intra-arterial cerebral infusion of Avastin (bevacizumab) directly into a patient's malignant brain tumor. This novel intra-arterial (IA) technique may expose the cancer to higher doses of the drug therapy, while possibly sparing the patient common side effects of receiving the drug intravenously (IV) or throughout their body.
Neurosurgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical Center performed the world's first intra-arterial cerebral infusion of Avastin (bevacizumab) directly into a patient's malignant brain tumor. This novel intra-arterial (IA) technique may expose the cancer to higher doses of the drug therapy, while possibly sparing the patient common side effects of receiving the drug intravenously (IV) or throughout their body.
Battling Cancer With Engineering: NCI Funds New $13 Million Microenvironment and Metastasis Research Center at Cornell University and Weill Cornell Medical College
Adding potent research firepower and fresh physical perspectives to combat cancer, the National Cancer Institute (NCI) has funded the new Center on the Microenvironment and Metastasis, which will be headquartered at Cornell University. It is one of 12 new research centers across the nation recently announced by the NCI. This grant is for $13 million over five years.
Cornell will serve as the lead institution in a partnership with the Weill Cornell Medical College in New York City and the University at Buffalo. The Center will focus on using nanobiotechnology and other related physical science approaches to advance the research on cancer.
Adding potent research firepower and fresh physical perspectives to combat cancer, the National Cancer Institute (NCI) has funded the new Center on the Microenvironment and Metastasis, which will be headquartered at Cornell University. It is one of 12 new research centers across the nation recently announced by the NCI. This grant is for $13 million over five years.
Cornell will serve as the lead institution in a partnership with the Weill Cornell Medical College in New York City and the University at Buffalo. The Center will focus on using nanobiotechnology and other related physical science approaches to advance the research on cancer.
Minimally Invasive Surgery Shown Safe and Effective Treatment for Rectal Cancer
Laparoscopic surgery has been used in the treatment of intestinal disorders for close to 20 years, but its benefits have only recently begun to be extended to people with rectal cancer. In a prospective study of 103 patients who underwent straightforward or "hand-assisted" laparoscopic surgery for rectal cancer, a team of colon and rectal surgeons at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has shown that the minimally invasive approach can be as effective as traditional open surgery in treating rectal cancers.
The advantages of laparoscopic and other minimally invasive surgical techniques are well known. After laparoscopic surgery, patients experience shorter hospital stays, smaller scars, far less pain and faster recovery, compared with open surgery. NewYork-Presbyterian/Weill Cornell has offered these procedures for many years, and continues to be at the forefront of innovation, applying the minimally invasive approach to diseases and conditions once considered treatable mainly using open surgery techniques. Until recently, rectal cancer was one such disease -- and its treatment via laparoscopic surgery is still seen by some as controversial.
Laparoscopic surgery has been used in the treatment of intestinal disorders for close to 20 years, but its benefits have only recently begun to be extended to people with rectal cancer. In a prospective study of 103 patients who underwent straightforward or "hand-assisted" laparoscopic surgery for rectal cancer, a team of colon and rectal surgeons at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has shown that the minimally invasive approach can be as effective as traditional open surgery in treating rectal cancers.
The advantages of laparoscopic and other minimally invasive surgical techniques are well known. After laparoscopic surgery, patients experience shorter hospital stays, smaller scars, far less pain and faster recovery, compared with open surgery. NewYork-Presbyterian/Weill Cornell has offered these procedures for many years, and continues to be at the forefront of innovation, applying the minimally invasive approach to diseases and conditions once considered treatable mainly using open surgery techniques. Until recently, rectal cancer was one such disease -- and its treatment via laparoscopic surgery is still seen by some as controversial.
